Published in Br J Cancer on September 01, 1995
The NQO1 polymorphism C609T (Pro187Ser) and cancer susceptibility: a comprehensive meta-analysis. Br J Cancer (2013) 1.75
Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase). Br J Cancer (1997) 1.42
High throughput genotyping for the detection of a single nucleotide polymorphism in NAD(P)H quinone oxidoreductase (DT diaphorase) using TaqMan probes. Mol Pathol (1999) 1.35
A polymorphism in NAD(P)H:quinone oxidoreductase (NQO1): relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity. Br J Cancer (1996) 1.19
Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes. Carcinogenesis (2008) 1.11
NQO1 C609T polymorphism associated with esophageal cancer and gastric cardiac carcinoma in North China. World J Gastroenterol (2003) 1.11
A functional NQO1 609C>T polymorphism and risk of gastrointestinal cancers: a meta-analysis. PLoS One (2012) 0.88
NQO1 gene rs1800566 variant is not associated with risk for multiple sclerosis. BMC Neurol (2014) 0.84
Induction of DT-diaphorase by 1,2-dithiole-3-thiones in human tumour and normal cells and effect on anti-tumour activity of bioreductive agents. Br J Cancer (1998) 0.83
Association between NQO1 C609T polymorphism and acute lymphoblastic leukemia risk: evidence from an updated meta-analysis based on 17 case-control studies. J Cancer Res Clin Oncol (2014) 0.82
Lack of association between NADPH quinone oxidoreductase 1 (NQO1) gene C609T polymorphism and lung cancer: a case-control study and a meta-analysis. PLoS One (2012) 0.82
Genetic factors associated with intestinal metaplasia in a high risk Singapore-Chinese population: a cohort study. BMC Gastroenterol (2009) 0.82
Assessment of the relationship between genotypic status of a DT-diaphorase point mutation and enzymatic activity. Br J Cancer (2000) 0.80
Transfection of COS-1 cells with DT-diaphorase cDNA: role of a base change at position 609. Br J Cancer (1998) 0.79
The NQO1 Pro187Ser polymorphism and breast cancer susceptibility: evidence from an updated meta-analysis. Diagn Pathol (2014) 0.79
NQO1 C609T polymorphism and esophageal cancer risk: a HuGE review and meta-analysis. BMC Med Genet (2013) 0.78
Genetic polymorphism 609C>T in NAD(P)H:quinone oxidoreductase 1 enhances the risk of proximal colon cancer. J Hum Genet (2014) 0.76
Immortalisation of a human diploid fibroblast cell strain: a DT-diaphorase paradox. Br J Cancer Suppl (1996) 0.75
Gene polymorphisms in the ornithine decarboxylase-polyamine pathway modify gastric cancer risk by interaction with isoflavone concentrations. Gastric Cancer (2014) 0.75
'Touchdown' PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res (1991) 19.71
Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J (1984) 13.20
An improved method for directly sequencing PCR amplified material using dimethyl sulphoxide. Nucleic Acids Res (1989) 10.50
Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci U S A (1990) 3.03
Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity. Proc Natl Acad Sci U S A (1980) 2.92
The metabolism of menadione (2-methyl-1,4-naphthoquinone) by isolated hepatocytes. A study of the implications of oxidative stress in intact cells. J Biol Chem (1982) 2.81
NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity. Cancer Res (1992) 1.91
DT-diaphorase and cancer chemotherapy. Biochem Pharmacol (1992) 1.78
DT-diaphorase in activation and detoxification of quinones. Bioreductive activation of mitomycin C. Cancer Metastasis Rev (1993) 1.58
Therapeutic attack of hypoxic cells of solid tumors: presidential address. Cancer Res (1988) 1.54
DT-diaphorase as a quinone reductase: a cellular control device against semiquinone and superoxide radical formation. Arch Biochem Biophys (1982) 1.51
Human dioxin-inducible cytosolic NAD(P)H:menadione oxidoreductase. cDNA sequence and localization of gene to chromosome 16. J Biol Chem (1988) 1.42
High levels of expression of the NAD(P)H:quinone oxidoreductase (NQO1) gene in tumor cells compared to normal cells of the same origin. Biochem Pharmacol (1991) 1.41
NAD(P)H:quinone oxidoreductase1 (DT-diaphorase) expression in normal and tumor tissues. Cancer Metastasis Rev (1993) 1.37
Human NAD(P)H:quinone oxidoreductase2. Gene structure, activity, and tissue-specific expression. J Biol Chem (1994) 1.33
Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6. Biochemistry (1990) 1.21
Bioreductive activation of mitomycin C by DT-diaphorase. Biochemistry (1992) 1.15
Drug-metabolizing enzymes in ligand-modulated transcription. Biochem Pharmacol (1994) 1.12
DT-diaphorase activity and mitomycin C sensitivity in non-transformed cell strains derived from members of a cancer-prone family. Carcinogenesis (1991) 1.05
Human FAD-dependent NAD(P)H diaphorase. Biochem J (1980) 1.05
Deficient activation by a human cell strain leads to mitomycin resistance under aerobic but not hypoxic conditions. Br J Cancer (1989) 1.03
Mechanism of monofunctional and bifunctional alkylation of DNA by mitomycin C. Biochemistry (1988) 1.00
Expression of NAD(P)H:quinone oxidoreductase and glutathione S-transferases alpha and pi in human renal cell carcinoma and in kidney cancer-derived cell lines. Carcinogenesis (1994) 1.00
Relationship between DT-diaphorase-mediated metabolism of a series of aziridinylbenzoquinones and DNA damage and cytotoxicity. Mol Pharmacol (1992) 0.96
Loss of heterozygosity at the NAD(P)H: quinone oxidoreductase locus associated with increased resistance against mitomycin C in a human bladder carcinoma cell line. Biol Chem Hoppe Seyler (1994) 0.95
Elevation of quinone reductase activity by anticarcinogenic antioxidants. Adv Enzyme Regul (1982) 0.93
Sarcomas and multiple polyposis in a kindred. A genetic variety of hereditary polyposis? Arch Intern Med (1968) 0.92
An interpretation of human diaphorase isozymes in terms of three gene loci DIA1, DIA2 and DIA3. Ann Hum Genet (1977) 0.91
Abnormal pattern of post-gamma-ray DNA replication in radioresistant fibroblast strains from affected members of a cancer-prone family with Li-Fraumeni syndrome. Br J Cancer (1995) 0.90
NAD(P)H (quinone acceptor) oxidoreductase (DT-diaphorase)-mediated two-electron reduction of anthraquinone-based antitumour agents and generation of hydroxyl radicals. Biochem Pharmacol (1992) 0.84
Characterization of a set of Chinese hamster ovary variant cell lines demonstrating differing sensitivity to mitomycin C. Oncol Res (1993) 0.81
A comparison of free radical formation by quinone antitumour agents in MCF-7 cells and the role of NAD(P)H (quinone-acceptor) oxidoreductase (DT-diaphorase). Chem Biol Interact (1993) 0.81
The clinical pharmacology of oral and inhaled salbutamol. Clin Pharmacol Ther (1973) 4.56
Xeroderma pigmentosum cells with normal levels of excision repair have a defect in DNA synthesis after UV-irradiation. Proc Natl Acad Sci U S A (1975) 4.02
Isoprenaline resistance and the use of pressurised aerosols in asthma. Lancet (1968) 3.33
Comparison of cardiorespiratory effects of isoprenaline and salbutamol in patients with bronchial asthma. Br Med J (1970) 3.25
Principles and applications of ultrasound backscatter microscopy. IEEE Trans Ultrason Ferroelectr Freq Control (1993) 2.98
Clinical assessment of bronchodilator drugs delivered by aerosol. Thorax (1973) 2.64
An in vitro assay to measure the viability of KHT tumor cells not previously exposed to culture conditions. Radiat Res (1974) 2.62
A comparison of three different techniques for giving nebulized albuterol to asthmatic patients. Am Rev Respir Dis (1974) 2.57
Effect of propranolol in mild hypertension. Lancet (1966) 2.57
Excision-repair properties of an Escherichia coli mutant deficient in DNA polymerase. Nature (1970) 2.30
Increased cell killing by metronidazole and nitrofurazone of hypoxic compared to aerobic mammalian cells. Cancer Res (1976) 2.26
Bronchodilator drugs. Am Rev Respir Dis (1979) 2.24
SElectivity of broncholidlator action of salbutamol in asthmatic patients. Br J Dis Chest (1971) 2.15
Influence of the epithelium on responsiveness of guinea-pig isolated trachea to contractile and relaxant agonists. Br J Pharmacol (1986) 2.07
The metabolic fate of DL(7-3H)isoprenaline in man and dog. Biochem J (1969) 2.06
I. Ophthalmoscopic and circulatory changes in focal retinal ischaemia. Br J Ophthalmol (1966) 1.99
The fate of ( 14 C)disodium cromoglycate in man. J Pharm Pharmacol (1972) 1.97
Clinical pharmacology of beta-receptor-blocking drugs. Clin Pharmacol Ther (1970) 1.92
Defective excision repair of gamma-ray-damaged DNA in human (ataxia telangiectasia) fibroblasts. Nature (1976) 1.90
A comparison of salbutamol given by pressure-packed aerosol or nebulization via IPPB in acute asthma. Br J Dis Chest (1978) 1.89
The metabolism of salbutamol in man. Xenobiotica (1973) 1.88
In vivo testing of hypoxic radiosensitizers using the KHT murine tumour assayed by the lung-colony technique. Br J Radiol (1975) 1.86
Use of UV endonuclease from Micrococcus luteus to monitor the progress of DNA repair in UV-irradiated human cells. Mutat Res (1973) 1.75
In vitro responsiveness of human asthmatic bronchus to carbachol, histamine, beta-adrenoceptor agonists and theophylline. Br J Clin Pharmacol (1986) 1.73
Pten (phosphatase and tensin homologue gene) haploinsufficiency promotes insulin hypersensitivity. Diabetologia (2006) 1.72
Experimental retinal branch vein occlusion. Am J Ophthalmol (1970) 1.72
Ultraviolet- and X-ray-induced responses of a deoxyribonucleic acid polymerase-deficient mutant of Escherichia coli. J Bacteriol (1971) 1.59
Complementation analysis of ataxia-telangiectasia. Kroc Found Ser (1985) 1.58
Inactivation of the cellular p53 gene is a common feature of Friend virus-induced erythroleukemia: relationship of inactivation to dominant transforming alleles. Mol Cell Biol (1990) 1.58
Clinical pharmacology of beta-reccer-atefoygolocarahp lnilcc clinical pharmacology of beta-receptor-blocking drugs. Clin Pharmacol Ther (1969) 1.56
Interaction of corticosteroids and catecholamines in the treatment of asthma. Thorax (1975) 1.52
The fate of nebulized salbutamol (albuterol) administered by intermittent positive pressure respiration to asthmatic patients. Am Rev Respir Dis (1973) 1.51
Beta-adrenergic blocking drugs. Br Med J (1971) 1.49
Stereospecific removal of methyl phosphotriesters from DNA by an Escherichia coli ada+ extract. Nucleic Acids Res (1985) 1.48
Evidence for dark-reactivation of ultraviolet light damage in mouse L cells. Radiat Res (1967) 1.47
Pharmacokinetics of inhaled salbutamol in asthmatic patients. Br J Pharmacol (1971) 1.47
Plasma prednisolone levels in man following administration in plain and enteric-coated forms. Br J Clin Pharmacol (1977) 1.46
Polybrene/DMSO-assisted gene transfer. Generating stable transfectants with nanogram amounts of DNA. Mol Biotechnol (1994) 1.43
Plasma prednisolone levels after administration of prednisolone-21-phosphate as a retention enema in colitis. Br Med J (1976) 1.42
Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome. Cancer Res (1994) 1.39
Effect of raised intraocular pressure on the retinal and choroidal circulation. Invest Ophthalmol (1968) 1.38
Metabolism of isoprenaline in dog and man. Br J Pharmacol (1972) 1.38
Pharmacological responses of human and porcine lung parenchyma, bronchus and pulmonary artery. Br J Pharmacol (1982) 1.33
The Physical State of Viral Nucleic Acid and the Sensitivity of Viruses to Ultraviolet Light. Biophys J (1965) 1.29
Endonucleolytic activity from Micrococcus luteus that acts on -ray-induced damage in plasmid DNA of Escherichia coli minicells. Proc Natl Acad Sci U S A (1972) 1.29
Molecular mechanisms for the hypoxia-dependent activation of 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233). Biochem Pharmacol (1988) 1.28
Distribution of polypyrimidine . polypurine segments in DNA from diverse organisms. Eur J Biochem (1979) 1.28
The interaction of caffeine with ultra-violet-light-irradiated DNA. Int J Radiat Biol Relat Stud Phys Chem Med (1970) 1.27
Effect of intravenous injection of salbutamol in asthma. Br J Clin Pharmacol (1975) 1.26
Ataxia telangiectasia: an inherited human disorder involving hypersensitivity to ionizing radiation and related DNA-damaging chemicals. Annu Rev Genet (1979) 1.25
Radiogenic male breast cancer with in vitro sensitivity to ionizing radiation and bleomycin. Cancer Invest (1983) 1.24
Selective hydrolysis by exo- and endonucleases of phosphodiester bonds adjacent to an apurinic site. Nucleic Acids Res (1989) 1.23
Chromosome 11 uniparental isodisomy predisposing to embryonal neoplasms. Lancet (1991) 1.23
A third Wilms' tumor locus on chromosome 16q. Cancer Res (1992) 1.20
Differences in the toxicity and metabolism of the 2-nitroimidazole misonidazole (Ro-07-0582) in HeLa and Chinese hamster ovary cells. Cancer Res (1978) 1.19
A polymorphism in NAD(P)H:quinone oxidoreductase (NQO1): relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity. Br J Cancer (1996) 1.19
Blood-levels of fluorinated hydrocarbons in asthmatic patients after inhalation of pressurised aerosols. Lancet (1971) 1.18
An experimental and analytical study of oxygen depletion in stirred cell suspensions. Radiat Res (1980) 1.18
Properties of uvrE mutants of Escherichia coli K12. I. Effects of UV irradiation on DNA metabolism. Mutat Res (1974) 1.17
Testing of hypoxic cell radiosensitizers in vivo. Br J Cancer Suppl (1978) 1.16
Comparative efficacy of salbutamol by pressurized aerosol and wet nebulizer in acute asthma. Br J Clin Pharmacol (1980) 1.16
A site-directed approach for constructing temperature-sensitive ubiquitin-conjugating enzymes reveals a cell cycle function and growth function for RAD6. J Biol Chem (1991) 1.16
Nascent DNA synthesis in ultraviolet light-irradiated mouse L cells. Biochim Biophys Acta (1972) 1.15
Photoreversal-dependent release of thymidine and thymidine monophosphate from pyrimidine dimer-containing DNA excision fragments isolated from ultraviolet-damaged human fibroblasts. Biochemistry (1986) 1.15
Effect of steroids on beta-adrenoceptor-mediated relaxation of pig bronchus. Br J Pharmacol (1983) 1.15
Protein-tyrosine phosphatase alpha regulates Src family kinases and alters cell-substratum adhesion. J Biol Chem (1998) 1.14
Ultraviolet irradiation of mouse L cells: effects on DNA synthesis and progression through the cell cycle. Radiat Res (1968) 1.14
Organization, expression and polymorphism of the human persyn gene. Hum Mol Genet (1998) 1.14
Measurement of plasma prednisolone in man. Br J Clin Pharmacol (1975) 1.13
Co-axial bioassay of a smooth muscle relaxant factor released from guinea-pig tracheal epithelium. Br J Pharmacol (1989) 1.13
Adverse reactions to beta 2-agonist bronchodilators. Med Toxicol (1986) 1.12
Effects of caffeine on ultraviolet-irradiated mouse L cells. Radiat Res (1969) 1.10
Amiloride hydrochloride in hypertensive patients. Br Med J (1968) 1.09
Pharmacology and toxicology of sensitizers: mechanism studies. Int J Radiat Oncol Biol Phys (1984) 1.08
Enhanced radiosensitivity of cultured fibroblasts from ataxia telangiectasia heterozygotes manifested by defective colony-forming ability and reduced DNA repair replication after hypoxic gamma-irradiation. Cancer Res (1979) 1.07
A study of doxorubicin loading onto and release from sulfopropyl dextran ion-exchange microspheres. J Control Release (2001) 1.07
Effect of restrictions on prescribing patterns for dextropropoxyphene. Br Med J (1980) 1.06
DT-diaphorase activity and mitomycin C sensitivity in non-transformed cell strains derived from members of a cancer-prone family. Carcinogenesis (1991) 1.05
Activity of mitomycin C for aerobic and hypoxic cells in vitro and in vivo. Cancer Res (1983) 1.05
Effects of dimethyl sulfoxide and hypoxic cell radiosensitizers on the radiation response of the KHT murine tumor in vivo. Radiat Res (1977) 1.04
Deficient activation by a human cell strain leads to mitomycin resistance under aerobic but not hypoxic conditions. Br J Cancer (1989) 1.03
Enzymatic analysis of isomeric trithymidylates containing ultraviolet light-induced cyclobutane pyrimidine dimers. I. Nuclease P1-mediated hydrolysis of the intradimer phosphodiester linkage. J Biol Chem (1989) 1.03
Hemoglobin genes in non-legumes: cloning and characterization of a Casuarina glauca hemoglobin gene. Plant Mol Biol (1991) 1.03
Classification of beta-adrenoceptors in human isolated bronchus. Br J Pharmacol (1984) 1.03
Metabolic processing of cyclobutyl pyrimidine dimers and (6-4) photoproducts in UV-treated human cells. Evidence for distinct excision-repair pathways. J Biol Chem (1994) 1.03
Assessment of chronic gamma radiosensitivity as an in vitro assay for heterozygote identification of ataxia-telangiectasia. Radiat Res (1991) 1.03
Correlations between pharmacological responses and structure of human lung parenchyma strips. Br J Pharmacol (1983) 1.01
Autoradiographic localization of beta-adrenoceptors in asthmatic human lung. Am Rev Respir Dis (1989) 1.01
-Ray-induced chain breaks and alkali-labile bonds in lambda d upsilon DNA of Escherichia coli minicells irradiated under aerobic and anoxic conditions. Int J Radiat Biol Relat Stud Phys Chem Med (1973) 1.00
Response of phage T4 polynucleotide kinase toward dinucleotides containing apurinic sites: design of a 32P-postlabeling assay for apurinic sites in DNA. Biochemistry (1990) 0.98
Arterial fluorescein studies in diabetic retinopathy. Diabetes (1967) 0.98
Transmission of in-vitro radioresistance in a cancer-prone family. Lancet (1981) 0.97
Differential expression and stability of foreign genes introduced into human fibroblasts by nuclear versus cytoplasmic microinjection. Mutat Res (1992) 0.97
Human pharmacology: comparison of intravenous isoprenaline and salbutamol in asthmatic patients. Postgrad Med J (1971) 0.97
The metabolism and pharmacokinetics of the hypoxic cell radiosensitizer and cytotoxic agent, misonidazole, in C3H mice. Radiat Res (1981) 0.97
Evaluation of treatment response in patients with seasonal allergic rhinitis using domiciliary nasal peak inspiratory flow. Clin Exp Allergy (2000) 0.96
DNA repair monitored by an enzymatic assay in multinucleate xeroderma pigmentosum cells after fusion. Nature (1974) 0.96
Nascent DNA synthesis in ultraviolet light-irradiated mouse, human and Chinese hamster cells. Biophys J (1974) 0.96